These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 7776786

  • 1. Does interferon beta cause initial exacerbation of multiple sclerosis?
    Rudge P, Miller D, Crimlisk H, Thorpe J.
    Lancet; 1995 Mar 04; 345(8949):580. PubMed ID: 7776786
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of multiple sclerosis using recombinant interferon-beta].
    Polman CH, Barkhof F, van Loenen AC, Lucas CJ, Koetsier JC.
    Ned Tijdschr Geneeskd; 1994 Jan 01; 138(1):7-10. PubMed ID: 8289963
    [No Abstract] [Full Text] [Related]

  • 3. Role of interferons in demyelinating disease.
    Johnson KP.
    J Neural Transm Suppl; 1997 Jan 01; 49():111-5. PubMed ID: 9266420
    [Abstract] [Full Text] [Related]

  • 4. A pilot study of MRI activity before and during interferon beta-1a therapy.
    Waubant E, Goodkin DE, Sloan R, Andersson PB.
    Neurology; 1999 Sep 11; 53(4):874-6. PubMed ID: 10489060
    [Abstract] [Full Text] [Related]

  • 5. Interferon beta-1b for the treatment of multiple sclerosis.
    Petri T, Weber-Diehl F.
    J Biotechnol; 1995 Nov 21; 43(1):74-5. PubMed ID: 8573325
    [No Abstract] [Full Text] [Related]

  • 6. Brain atrophy, interferon beta, and treatment trials in multiple sclerosis.
    Miller DH.
    Lancet; 1995 Nov 21; 364(9444):1463-4. PubMed ID: 15500870
    [No Abstract] [Full Text] [Related]

  • 7. Role of interferons in demyelinating diseases.
    Arnason BG, Toscas A, Dayal A, Qu Z, Noronha A.
    J Neural Transm Suppl; 1997 Nov 21; 49():117-23. PubMed ID: 9266421
    [Abstract] [Full Text] [Related]

  • 8. Immunotherapy for MS: clinical aspects and trials.
    Ebers GC, Sibley WA, Paty DW.
    Acta Neurol Scand Suppl; 1995 Nov 21; 161():54. PubMed ID: 7653246
    [No Abstract] [Full Text] [Related]

  • 9. The interferon-beta 1b clinical trial and its implications for other trials.
    Paty DW.
    Ann Neurol; 1994 Nov 21; 36 Suppl():S113-4. PubMed ID: 8017869
    [Abstract] [Full Text] [Related]

  • 10. Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial.
    Filippi M, Rovaris M, Inglese M, Barkhof F, De Stefano N, Smith S, Comi G.
    Lancet; 1994 Nov 21; 364(9444):1489-96. PubMed ID: 15500893
    [Abstract] [Full Text] [Related]

  • 11. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, Priore RL, Pullicino PM, Scherokman BJ, Whitham RH.
    Ann Neurol; 1996 Mar 21; 39(3):285-94. PubMed ID: 8602746
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group.
    Simon JH, Jacobs LD, Campion M, Wende K, Simonian N, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Alam JJ, Fischer JS, Goodkin DE, Granger CV, Lajaunie M, Martens-Davidson AL, Meyer M, Sheeder J, Choi K, Scherzinger AL, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Whitham RH.
    Ann Neurol; 1998 Jan 21; 43(1):79-87. PubMed ID: 9450771
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group.
    Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, Simonian NA, Slasor PJ, Sandrock AW.
    N Engl J Med; 2000 Sep 28; 343(13):898-904. PubMed ID: 11006365
    [Abstract] [Full Text] [Related]

  • 19. [Effect of weekly intramuscular interferon beta-1a on MRI lesions in patients with relapsing multiple sclerosis].
    Waubant E, Sloan R, Andersson PB, Goodkin D.
    Rev Neurol (Paris); 1999 Sep 28; 155 Suppl 2():S20-3. PubMed ID: 10367321
    [Abstract] [Full Text] [Related]

  • 20. Trial of interferon-beta in multiple sclerosis stopped early.
    Bonn D.
    Lancet; 1998 Feb 21; 351(9102):573. PubMed ID: 9492786
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.